BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26589647)

  • 1. Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian Cohort.
    Toomsoo T; Liepelt-Scarfone I; Kerner R; Kadastik-Eerme L; Asser T; Rubanovits I; Berg D; Taba P
    J Ultrasound Med; 2016 Jan; 35(1):17-23. PubMed ID: 26589647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
    Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
    J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to measure substantia nigra hyperechogenicity in Parkinson disease: detailed guide with video.
    Walter U
    J Ultrasound Med; 2013 Oct; 32(10):1837-43. PubMed ID: 24065265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transcranial sonography for the diagnosis of Parkinson disease].
    Venegas F P; Miranda G G; Silva C MC
    Rev Med Chil; 2011 Jan; 139(1):54-9. PubMed ID: 21526317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
    Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
    Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the substantia nigra by means of transcranial ultrasound imaging].
    Vivo-Orti MN; Tembl JI; Sastre-Bataller I; Vazquez-Costa JF; Sahuquillo P; Burguera JA
    Rev Neurol; 2013 Mar; 56(5):268-74. PubMed ID: 23440754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
    López Hernández N; García Escrivá A; Shalabi Benavent M
    Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
    Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
    J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new assessment tool for Parkinson disease: the nigral lesion load obtained by transcranial sonography.
    Sanzaro E; Iemolo F; Duro G; Malferrari G
    J Ultrasound Med; 2014 Sep; 33(9):1635-40. PubMed ID: 25154946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.
    Busse K; Heilmann R; Kleinschmidt S; Abu-Mugheisib M; Höppner J; Wunderlich C; Gemende I; Kaulitz L; Wolters A; Benecke R; Walter U
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):441-7. PubMed ID: 22362921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
    Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
    Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor.
    Sprenger FS; Wurster I; Seppi K; Stockner H; Scherfler C; Sojer M; Schmidauer C; Berg D; Poewe W
    Mov Disord; 2016 Apr; 31(4):579-83. PubMed ID: 26893155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson's disease: A Systematic Review and Meta-analysis.
    Li DH; He YC; Liu J; Chen SD
    Sci Rep; 2016 Feb; 6():20863. PubMed ID: 26878893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease.
    Huang YW; Jeng JS; Tsai CF; Chen LL; Wu RM
    Mov Disord; 2007 Mar; 22(4):550-5. PubMed ID: 17260344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease.
    van de Loo S; Walter U; Behnke S; Hagenah J; Lorenz M; Sitzer M; Hilker R; Berg D
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1087-92. PubMed ID: 20543186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons.
    Berg D; Seppi K; Behnke S; Liepelt I; Schweitzer K; Stockner H; Wollenweber F; Gaenslen A; Mahlknecht P; Spiegel J; Godau J; Huber H; Srulijes K; Kiechl S; Bentele M; Gasperi A; Schubert T; Hiry T; Probst M; Schneider V; Klenk J; Sawires M; Willeit J; Maetzler W; Fassbender K; Gasser T; Poewe W
    Arch Neurol; 2011 Jul; 68(7):932-7. PubMed ID: 21747034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperechogenicity of the substantia nigra in Parkinson's disease.
    Ressner P; Skoloudík D; Hlustík P; Kanovský P
    J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis.
    Heim B; Peball M; Hammermeister J; Djamshidian A; Krismer F; Seppi K
    J Parkinsons Dis; 2022; 12(4):1115-1123. PubMed ID: 35180133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.